Carcinoma Midline

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-03-16
Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers [Phase 1]
Phase 1 study of GSK525762 in NUT midline carcinoma and other cancers completed; results posted.